KROS

Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative therapies aimed at addressing significant unmet medical needs in hematological and musculoskeletal disorders. Headquartered in Lexington, Massachusetts, the company is advancing its proprietary pipeline of drug candidates designed to improve patient outcomes in these challenging therapeutic areas. With a strong focus on scientific innovation, Keros is positioned to make a meaningful impact on the lives of patients and expand treatment options in the biopharmaceutical landscape.